CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.606
-0.029 (-4.52%)
At close: Mar 6, 2026, 4:00 PM EST
0.618
+0.012 (2.00%)
After-hours: Mar 6, 2026, 4:35 PM EST
CollPlant Biotechnologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 2.48 | 0.52 | 10.96 | 0.3 | 15.64 | 6.14 | |
| Revenue Growth (YoY) | 280.77% | -95.30% | 3565.22% | -98.09% | 154.86% | 164.75% | |
| Cost of Revenue | 0.92 | 1.63 | 1.99 | 0.4 | 2.01 | 3 | |
| Gross Profit | 1.56 | -1.11 | 8.97 | -0.1 | 13.64 | 3.14 | |
| Selling, General & Admin | 5.12 | 5.63 | 6 | 6.74 | 5.94 | 4.67 | |
| Research & Development | 8.75 | 10.52 | 10.48 | 10.26 | 7.63 | 4.07 | |
| Operating Expenses | 13.87 | 16.14 | 16.48 | 17 | 13.57 | 8.73 | |
| Operating Income | -12.31 | -17.25 | -7.51 | -17.1 | 0.07 | -5.6 | |
| Interest Expense | - | - | - | -0.02 | -0.01 | -0.02 | |
| Interest & Investment Income | 0.24 | 0.74 | 0.79 | 0.32 | 0.22 | - | |
| Currency Exchange Gain (Loss) | -0.08 | -0.08 | -0.29 | -0.12 | -0.04 | -0.18 | |
| Other Non Operating Income (Expenses) | -0.02 | -0.02 | -0.01 | -0.01 | -0 | 0.03 | |
| Pretax Income | -12.16 | -16.61 | -7.02 | -16.93 | 0.24 | -5.77 | |
| Net Income | -12.16 | -16.61 | -7.02 | -16.93 | 0.24 | -5.77 | |
| Net Income to Common | -12.16 | -16.61 | -7.02 | -16.93 | 0.24 | -5.77 | |
| Shares Outstanding (Basic) | 12 | 11 | 11 | 11 | 10 | 7 | |
| Shares Outstanding (Diluted) | 12 | 11 | 11 | 11 | 12 | 7 | |
| Shares Change (YoY) | 3.64% | 0.57% | 3.23% | -7.80% | 73.76% | 38.12% | |
| EPS (Basic) | -1.02 | -1.45 | -0.62 | -1.53 | 0.02 | -0.84 | |
| EPS (Diluted) | -1.02 | -1.45 | -0.62 | -1.53 | 0.02 | -0.84 | |
| Free Cash Flow | -10.02 | -14.58 | -3.72 | -14.97 | 1.07 | -4.89 | |
| Free Cash Flow Per Share | -0.84 | -1.27 | -0.33 | -1.36 | 0.09 | -0.71 | |
| Gross Margin | 63.03% | -215.53% | 81.83% | -33.78% | 87.18% | 51.08% | |
| Operating Margin | -497.25% | -3349.71% | -68.55% | -5718.06% | 0.42% | -91.23% | |
| Profit Margin | -491.31% | -3225.05% | -64.05% | -5660.53% | 1.52% | -94.08% | |
| Free Cash Flow Margin | -404.85% | -2830.29% | -33.92% | -5007.36% | 6.86% | -79.65% | |
| EBITDA | -11.37 | -16.21 | -6.41 | -16.02 | 0.84 | -4.94 | |
| EBITDA Margin | - | - | -58.49% | - | 5.36% | -80.48% | |
| D&A For EBITDA | 0.94 | 1.04 | 1.1 | 1.08 | 0.77 | 0.66 | |
| EBIT | -12.31 | -17.25 | -7.51 | -17.1 | 0.07 | -5.6 | |
| EBIT Margin | - | - | -68.55% | - | 0.42% | -91.23% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.